Summary report of a workshop discussion held on 19 November 2018, Palais des Academies, Brussels
On the 19th November 2018, a workshop discussion organized by the Federation of European Academies of Medicine (FEAM), defined the policy interventions and the medical actions to be taken by the European Commission and Member States to ensure the correct functioning of the vaccination programmes.
Although the vaccination has been one of the most important medical achievement of the 20th Century for the primary prevention of communicable diseases, to date vaccination programmes face major challenges in the EU such us declining coverage, supply shortages and vaccine hesitancy leading to refusal. In this context, the FEAM forum vaccination workshop provided a clear overview on how to improve public dialogue on vaccination and how to address concerns related to it. The overall prospective was given by the opinions from academies, WHO, NGOs, industry, European Commission and its key agency, European Centre for Disease Prevention and Control.
The major identified conclusions are described hereafter:
The EU academies of science and medicines and their networks will continuously bringing together all required disciplines and expertises to share data and perspectives and to clarify issues, to raise public, professional and policy-maker awareness, and to support and inform European Commission initiatives in sustainably tackling vaccine hesitancy, strengthening national programmes and supporting collaboration.
The FEAM European Biomedical Policy Forum provides a platform for discussion on key policy issues for the biomedical community.
The Forum is an initiative from the Federation of European Academies of Medicine (FEAM). It aims to bring together representatives from academia, research charities, industry, European and national trade associations and professional bodies, regulators, public health bodies, and patient and consumers groups. If you would like further information on the FEAM European Biomedical Policy Forum or becoming a partner, please contact email@example.com